References
- Alviggi C, Humaidan P, Howles CM, Tredway D, Hillier SG. 2009. Biological versus chronological ovarian age: implications for assisted reproductive technology. Reprod Biol Endocrinol. 7:101. doi:https://doi.org/10.1186/1477-7827-7-101.
- Anckaert E, Oktem M, Thies A, Cohen-Bacrie M, Daan NM, Schiettecatte J, Muller C, Topcu D, Groning A, Ternaux F, et al. 2016. Multicenter analytical performance evaluation of a fully automated anti-Mullerian hormone assay and reference interval determination. Clin Biochem. 49:260–267. doi:https://doi.org/10.1016/j.clinbiochem.2015.10.008.
- Atasever M, Soyman Z, Demirel E, Gencdal S, Kelekci S. 2016. Diminished ovarian reserve: is it a neglected cause in the assessment of recurrent miscarriage? A cohort study. Fertil Steril. 105:1236–1240. doi:https://doi.org/10.1016/j.fertnstert.2016.01.001.
- Bentzen JG, Forman JL, Johannsen TH, Pinborg A, Larsen EC, Andersen AN. 2013. Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging. J Clin Endocrinol Metab. 98:1602–1611. doi:https://doi.org/10.1210/jc.2012-1829.
- Borges E, Dpaf Braga A, Setti A, Figueira R, Iaconelli A Jr. 2017. The predictive value of serum concentrations of anti-Mullerian hormone for oocyte quality, fertilization, and implantation. JBRA Assist Reprod. 21:176–182. doi:https://doi.org/10.5935/1518-0557.20170035.
- Bungum L, Tagevi J, Jokubkiene L, Bungum M, Giwercman A, Macklon N, Andersen CY, Klausen TW, Torring N, Kumar A, et al. 2018. The impact of the biological variability or assay performance on AMH measurements: a prospective cohort study with AMH tested on three analytical assay-platforms. Front Endocrinol (Lausanne). 9:603. doi:https://doi.org/10.3389/fendo.2018.00603.
- de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. 2002. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 77:357–362. doi:https://doi.org/10.1016/S0015-0282(01)02993-4.
- Dewailly D, Laven J. 2019. AMH as the primary marker for fertility. Eur J Endocrinol. 181:D45–D51. doi:https://doi.org/10.1530/EJE-19-0373.
- Durlinger AL, Visser JA, Themmen AP. 2002. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction. 601–609. doi:https://doi.org/10.1530/rep.0.1240601.
- Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. 2003. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 18:323–327.
- Gigli I, Cushman RA, Wahl CM, Fortune JE. 2005. Evidence for a role for anti-Mullerian hormone in the suppression of follicle activation in mouse ovaries and bovine ovarian cortex grafted beneath the chick chorioallantoic membrane. Mol Reprod Dev. 71:480–488. doi:https://doi.org/10.1002/mrd.20338.
- Guibourdenche J, Lucidarme N. 2003. Anti-Mullerian hormone levels in serum from human fetuses and children: pattern and clinical interest. Mol Cell Endocrinol. 211:55–63. doi:https://doi.org/10.1016/j.mce.2003.09.011.
- Hadlow N, Longhurst K, McClements A, Natalwala J, Brown SJ, Matson PL. 2013. Variation in antimullerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response. Fertil Steril. 99:1791–1797. doi:https://doi.org/10.1016/j.fertnstert.2013.01.132.
- Hamilton K, Hadlow N, Roberts P, Sykes P, McClements A, Coombes J, Matson P. 2016. Longitudinal changes in maternal serum concentrations of antimullerian hormone in individual women during conception cycles and early pregnancy. Fertil Steril. 106:1407–13 e2. doi:https://doi.org/10.1016/j.fertnstert.2016.07.1113.
- Hassold T, Jacobs P, Kline J, Stein Z, Warburton D. 1980. Effect of maternal age on autosomal trisomies. Ann Hum Genet. 44:29–36. doi:https://doi.org/10.1111/j.1469-1809.1980.tb00943.x.
- Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH. 2011. A validated model of serum anti-mullerian hormone from conception to menopause. PLoS One. 6:e22024. doi:https://doi.org/10.1371/journal.pone.0022024.
- Kerkhof GF, Leunissen RW, Willemsen RH, de Jong FH, Visser JA, Laven JS, Hokken-Koelega AC. 2010. Influence of preterm birth and small birth size on serum anti-Mullerian hormone levels in young adult women. Eur J Endocrinol. 163:937–944. doi:https://doi.org/10.1530/EJE-10-0528.
- KOSIS. 2020. Mean age at first marriage of bridegroom and bride for provinces.
- Krassas G, Karras SN, Pontikides N. 2015. Thyroid diseases during pregnancy: a number of important issues. Hormones (Athens). 14:59–69. doi:https://doi.org/10.1007/BF03401381.
- Kuliev A, Cieslak J, Ilkevitch Y, Verlinsky Y. 2003. Chromosomal abnormalities in a series of 6,733 human oocytes in preimplantation diagnosis for age-related aneuploidies. Reprod Biomed Online. 6:54–59. doi:https://doi.org/10.1016/S1472-6483(10)62055-X.
- Landersoe SK, Birch Petersen K, Sorensen AL, Larsen EC, Martinussen T, Lunding SA, Kroman MS, Nielsen HS, Nyboe Andersen A. 2020. Ovarian reserve markers after discontinuing long-term use of combined oral contraceptives. Reprod Biomed Online. 40:176–186. doi:https://doi.org/10.1016/j.rbmo.2019.10.004.
- Lie Fong S, Baart EB, Martini E, Schipper I, Visser JA, Themmen AP, de Jong FH, Fauser BJ, Laven JS. 2008. Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online. 16:664–670. doi:https://doi.org/10.1016/S1472-6483(10)60480-4.
- Lyttle Schumacher BM, Jukic AMZ, Steiner AZ. 2018. Antimullerian hormone as a risk factor for miscarriage in naturally conceived pregnancies. Fertil Steril. 109:1065–71 e1. doi:https://doi.org/10.1016/j.fertnstert.2018.01.039.
- McCormack CD, Leemaqz SY, Furness DL, Dekker GA, Roberts CT. 2019. Anti-Mullerian hormone levels in recurrent embryonic miscarriage patients are frequently abnormal, and may affect pregnancy outcomes. J Obstet Gynaecol. 39:623–627. doi:https://doi.org/10.1080/01443615.2018.1552669.
- Munne S, Alikani M, Tomkin G, Grifo J, Cohen J. 2019. Reprint of: embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril. 112:e71–e80. doi:https://doi.org/10.1016/j.fertnstert.2019.08.076.
- Pils S, Promberger R, Springer S, Joura E, Ott J. 2016. Decreased ovarian reserve predicts inexplicability of recurrent miscarriage? A retrospective analysis. PLoS One. 11:e0161606. doi:https://doi.org/10.1371/journal.pone.0161606.
- Pils S, Stepien N, Kurz C, Nouri K, Promberger R, Ott J. 2017. Anti-Mullerian hormone is linked to the type of early pregnancy loss in idiopathic recurrent miscarriage: a retrospective cohort study. Reprod Biol Endocrinol. 15:60. doi:https://doi.org/10.1186/s12958-017-0278-x.
- Plante BJ, Beamon C, Schmitt CL, Moldenhauer JS, Steiner AZ. 2010. Maternal antimullerian hormone levels do not predict fetal aneuploidy. J Assist Reprod Genet. 27:409–414. doi:https://doi.org/10.1007/s10815-010-9433-4.
- Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate RL, Skakkebaek NE. 1999. Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab. 84:3836–3844. doi:https://doi.org/10.1210/jcem.84.10.6047.
- Shim SH, Ha HI, Jung YW, Shim SS, Cho YK, Kim JY, Lee KJ, Cha DH, Kim SH, Park HJ. 2015. Maternal antimullerian hormone as a predictor of fetal aneuploidy occurring in an early pregnancy loss. Obstet Gynecol Sci. 58:494–500. doi:https://doi.org/10.5468/ogs.2015.58.6.494.
- Sowers M, McConnell D, Gast K, Zheng H, Nan B, McCarthy JD, Randolph JF. 2010. Anti-Mullerian hormone and inhibin B variability during normal menstrual cycles. Fertil Steril. 94:1482–1486. doi:https://doi.org/10.1016/j.fertnstert.2009.07.1674.
- Springer D, Jiskra J, Limanova Z, Zima T, Potlukova E. 2017. Thyroid in pregnancy: from physiology to screening. Crit Rev Clin Lab Sci. 54:102–116. doi:https://doi.org/10.1080/10408363.2016.1269309.
- Stegmann BJ, Santillan M, Leader B, Smith E, Santillan D. 2015. Changes in antimullerian hormone levels in early pregnancy are associated with preterm birth. Fertil Steril. 104:347–55 e3. doi:https://doi.org/10.1016/j.fertnstert.2015.04.044.
- Tarasconi B, Tadros T, Ayoubi JM, Belloc S, de Ziegler D, Fanchin R. 2017. Serum antimullerian hormone levels are independently related to miscarriage rates after in vitro fertilization-embryo transfer. Fertil Steril. 108:518–524. doi:https://doi.org/10.1016/j.fertnstert.2017.07.001.
- Tremellen KP, Kolo M, Gilmore A, Lekamge DN. 2005. Anti-mullerian hormone as a marker of ovarian reserve. Aust N Z J Obstet Gynaecol. 45(1):20–24. doi:https://doi.org/10.1111/j.1479-828X.2005.00332.x.
- Vigier B, Picard JY, Tran D, Legeai L, Josso N. 1984. Production of anti-Mullerian hormone: another homology between Sertoli and granulosa cells. Endocrinology. 114:1315–1320. doi:https://doi.org/10.1210/endo-114-4-1315.
- Yarde F, Maas AH, Franx A, Eijkemans MJ, Drost JT, van Rijn BB, van Eyck J, van der Schouw YT, Broekmans FJ. 2014. Serum AMH levels in women with a history of preeclampsia suggest a role for vascular factors in ovarian aging. J Clin Endocrinol Metab. 99:579–586. doi:https://doi.org/10.1210/jc.2013-2902.
- Yoon PW, Freeman SB, Sherman SL, Taft LF, Gu Y, Pettay D, Flanders WD, Khoury MJ, Hassold TJ. 1996. Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study. Am J Hum Genet. 58:628–633.
- Zhu J, Li T, Xing W, Lin H, Ou J. 2018. Chronological age vs biological age: a retrospective analysis on age-specific serum anti-Mullerian hormone levels for 3280 females in reproductive center clinic. Gynecol Endocrinol. 34:890–894. doi:https://doi.org/10.1080/09513590.2018.1462317.